Biomaterial Database

Acute thrombosis in a contralateral kidney after radical nephrectomy: successful treatment by thrombolytic therapy using a tissue-type plasminogen activator. 1996

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

Department of Urology, Kita-Ibaraki Municipal General Hospital, Japan.

A 67-year-old male became anuric immediately after a right radical nephrectomy for renal cell carcinoma. The patient was diagnosed with an acute arterial thrombosis of the remaining kidney within 4 hours after surgery by both CT scan and angiography. Thrombolytic therapy was started by a transcatheteral infusion of tissue-type plasminogen activator (TPA) resulting in a complete recanalization. Hydration and systemic administration of heparin followed, and renal function recovered within 3 weeks. This is the first report of acute thrombosis in a contralateral renal artery immediately after a radical nephrectomy which was successfully treated with TPA. It is probable that compression of the contralateral renal artery by the retractor for an extended period of time during surgery led to this unfavorable condition.

UI	MeSH Term	Description	Entries
D007668	Kidney	Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.	Kidneys
D008297	Male		Males
D009392	Nephrectomy	Excision of kidney.	Heminephrectomy,Heminephrectomies,Nephrectomies
D010959	Tissue Plasminogen Activator	A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.	Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D010960	Plasminogen Activators	A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.	Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011183	Postoperative Complications	Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.	Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D012077	Renal Artery	A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.	Arteries, Renal,Artery, Renal,Renal Arteries
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D000792	Angiography	Radiography of blood vessels after injection of a contrast medium.	Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies

Related Publications

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease.

January 1995, Pediatric cardiology,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

[Thrombolytic therapy with tissue-type plasminogen activator].

July 1994, Nihon rinsho. Japanese journal of clinical medicine,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

[Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator].

February 2005, Zhonghua yi xue za zhi,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

[Experimental therapy of acute thrombosis using a tissue plasminogen activator].

January 1985, Patologicheskaia fiziologiia i eksperimental'naia terapiia,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

Recombinant tissue-type plasminogen activator in the treatment of acute renal artery thrombosis after kidney transplantation.

August 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

[Cerebral infarction--thrombolytic therapy by tissue-type plasminogen activator or prourokinase].

April 1989, Nihon rinsho. Japanese journal of clinical medicine,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

[Recombinant DNA technology in thrombolytic therapy: tissue-type plasminogen activator].

March 1991, Bollettino chimico farmaceutico,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

Tissue-type plasminogen activator for acute coronary thrombosis.

December 1987, The Medical letter on drugs and therapeutics,

M Tsutsumi, and S Kasaya, and J Sakurai, and T Maruyama, and H Akaza

Successful salvage of thrombosed arterio-venous fistula with thrombolytic therapy using tissue plasminogen activator.

January 2015, Indian journal of nephrology,